In a patient with hemoglobin 11.1 g/dL, serum iron 142 µg/dL, total iron‑binding capacity 400 µg/dL, and transferrin saturation 36%, what is the likely cause of the anemia and what further evaluation is recommended?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Anemia with Normal Iron Studies: Likely Anemia of Chronic Disease

This patient has anemia (Hgb 11.1 g/dL) with normal-to-adequate iron parameters (serum iron 142 µg/dL, transferrin saturation 36%, TIBC 400 µg/dL), which strongly suggests anemia of chronic disease (ACD) or another non-iron-deficiency cause rather than iron deficiency anemia.

Iron Status Interpretation

Your patient's iron studies are not consistent with iron deficiency:

  • Transferrin saturation of 36% is well above the threshold for iron deficiency (typically <20% indicates deficiency) 1
  • Serum iron of 142 µg/dL is normal-to-elevated (not low as expected in iron deficiency)
  • TIBC of 400 µg/dL is at the upper limit of normal but not markedly elevated as typically seen in iron deficiency

In iron deficiency anemia, you would expect:

  • Low serum iron
  • High TIBC (>400 µg/dL)
  • Low transferrin saturation (<16-20%)
  • Low ferritin (though you haven't provided this value)

Most Likely Diagnosis: Anemia of Chronic Disease

The combination of anemia with adequate iron stores and normal-to-high transferrin saturation points toward anemia of chronic disease 2. This condition is characterized by:

  • Hypoproliferative anemia
  • Normal or elevated serum ferritin
  • Low-normal to normal serum iron
  • Normal or low TIBC
  • Normal or mildly reduced transferrin saturation (typically >20%)
  • Impaired erythropoietin production and response

Required Further Evaluation

Essential Next Steps:

  1. Check serum ferritin - This is the critical missing value. In ACD, ferritin is typically normal or elevated (>100 µg/L), whereas in iron deficiency it would be <45 ng/mL 3

  2. Evaluate for underlying chronic conditions:

    • Chronic kidney disease (check creatinine, GFR)
    • Chronic heart failure
    • Inflammatory conditions (check CRP, ESR)
    • Malignancy screening if age-appropriate
    • Chronic infections
    • Autoimmune diseases
  3. Consider soluble transferrin receptor (sTfR) if ferritin is elevated and you suspect coexistent iron deficiency 4. An elevated sTfR in the setting of elevated ferritin suggests true iron deficiency masked by inflammation

Important Caveats:

Functional iron deficiency can occur in chronic conditions (particularly CKD and CHF) where ferritin may be elevated but iron utilization is impaired 1. In these specific contexts:

  • CKD: Iron deficiency defined as transferrin saturation ≤20% with ferritin ≤100 µg/L (predialysis) or ≤200 µg/L (hemodialysis)
  • CHF: Iron deficiency defined as ferritin <100 µg/L and/or transferrin saturation <20%

However, your patient's transferrin saturation of 36% argues against functional iron deficiency in these conditions.

Management Approach

Do not empirically treat with iron supplementation at this time. With transferrin saturation of 36%, iron therapy is unlikely to be beneficial and may cause harm through oxidative stress 5.

Instead:

  1. Complete the diagnostic workup (ferritin, inflammatory markers, renal function)
  2. Identify and treat the underlying chronic condition
  3. Consider erythropoietin-stimulating agents if anemia is due to CKD with inadequate erythropoietin production
  4. Reserve iron therapy only if ferritin is definitively low (<45 ng/mL) or if functional iron deficiency is confirmed in specific disease contexts (CKD, CHF) with appropriate specialist consultation 1

Related Questions

Should my patient continue iron supplementation given a serum iron of 36 µg/dL, total iron‑binding capacity of 344 µg/dL, and transferrin saturation of 11%?
What does an iron panel showing total iron‑binding capacity 368 µg/dL, ferritin 15 µg/L, serum iron 128 µg/dL, and transferrin saturation 35% indicate, and how should it be managed?
When should iron infusions be considered for a patient with total iron‑binding capacity 445 µg/dL, serum iron 32 µg/dL, transferrin saturation 7 % and ferritin 11 ng/mL?
How should I manage a patient with hemoglobin 7.5 g/dL and ferritin 4 ng/mL?
In a patient with chronic disease who has a hemoglobin of 10.8 g/dL and a ferritin of 35 ng/mL, is iron replacement therapy indicated?
What is a recommended technique for initiating peripheral intravenous access in a patient with excess adipose tissue in the arm?
How can I obtain peripheral IV access in a patient with deep arm veins when ultrasound is unavailable?
How should apixaban be discontinued and resumed around a Mohs surgery, considering the patient’s renal function and the size of the surgical defect?
Should a 19‑month‑old child with a hemoglobin of 11.1 g/dL and normal iron studies continue iron supplementation?
What is the differential diagnosis for post‑coital vaginal bleeding?
Can you interpret the cervical spine X‑ray of a 79‑year‑old female presenting with new left‑hand tingling, wrist pain, radiating arm sensation, and chronic neck discomfort?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.